Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder

Clinical trial NCT06651177 · RECRUITING

Trial details

NCT number: NCT06651177
Sponsor: T. John Winhusen, PhD
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Opioid Use Disorder Opioid Use Disorder, Moderate Opioid Use Disorder, Severe

Start date: 2026-01-29
Primary completion: 2027-09-30
Enrollment: 310

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.